Stockreport

Nektar Therapeutics (NKTR) Is Up 12.1% After REZPEG Data And Lawsuits Collide - Has The Bull Case Changed? [Yahoo! Finance]

Nektar Therapeutics  (NKTR) 
Last nektar therapeutics earnings: 2/27 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nektar.com/investor-relations
PDF the 2026 American Academy of Dermatology meeting, alongside plans to start a Phase 3 atopic dermatitis program in the second quarter of 2026. At the same time, the com [Read more]